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Human neuroblastoma cellGq/11-coupledmuscarinic acetylcholine receptors (mAChRs) belonging toM1,M3 andM5 subtypes have been shown
to activate the metabolic sensor AMP-activated protein kinase (AMPK) through Ca2+/calmodulin-dependent pro-
tein kinase kinase-β (CaMKKβ)-mediated phosphorylation at Thr172. However, the source of Ca2+ required for
this response has not been yet elucidated. Here, we investigated the involvement of store-operated Ca2+ entry
(SOCE) in AMPK activation by pharmacologically deﬁned M3 mAChRs in human SH-SY5Y neuroblastoma cells. In
Ca2+-free medium the cholinergic agonist carbachol (CCh) caused a transient increase of phospho-Thr172 AMPK
that rapidly ceased within 2 min. Conversely, in the presence of extracellular Ca2+ CCh-induced AMPK phosphory-
lation lasted for at least 180 min. The SOCE modulator 2-aminoethoxydiphephenyl borate (2-APB), at a concentra-
tion (50 μM) that suppressed CCh-induced intracellular Ca2+ ([Ca2+]i) plateau, inhibited CCh-induced AMPK
phosphorylation. CCh triggered the activation of the endoplasmic reticulum Ca2+ sensor stromal interaction mole-
cule (STIM) 1, as indicated by redistribution of STIM1 immunoﬂuorescence into puncta, and promoted the associa-
tion of STIM1 with the SOCE channel component Orai1. Cell depletion of STIM1 by siRNA treatment reduced both
CCh-induced [Ca2+]i plateau andAMPK activation.M3mAChRs increased glucose uptake and this response required
extracellular Ca2+ and was inhibited by 2-APB, STIM1 knockdown, CaMKKβ and AMPK inhibitors, and adenovirus
infection with dominant negative AMPK. Thus, the study provides evidence that SOCE is required for sustained ac-
tivation of AMPK and stimulation of downstream glucose uptake byM3mAChRs and suggests that SOCE is a critical
process connecting M3 mAChRs to the control of neuronal energy metabolism.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Recent studies have shown that Gq/11-coupledmuscarinic acetylcho-
line receptors (mAChRs)1 belonging to the M3 and M1 subtypes are in-
volved in the regulation of energy metabolism and maintenance of
physiological blood glucose levels. Thus, by using M3 mAChR knockout
and transgenic mice it has been demonstrated that M3 mAChRs exertSciences, University of Cagliari,
o, Cagliari, Italy. Tel.: +39 070
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tor potential canonicala marked stimulatory effect on insulin release and play a role in the
parasympathetic control of blood glucose homeostasis [1,2]. Mice lack-
ing M3 mAChRs show a decrease in food intake and a reduction in
body fat mass, sympathetic outﬂow and whole-body energy consump-
tion [3,4]. Moreover, activation of M1 mAChRs has been reported to
stimulate glucose uptake into rat skeletal muscle [5].
The serine/threonine kinase AMP-activated protein kinase (AMPK)
plays a fundamental role in maintaining cellular energy homeostasis
by switching on catabolic pathways that produce ATP and inhibiting
ATP-consuming events. Thus, AMPK inhibits protein synthesis, pro-
motes glycogenolysis, stimulates glucose uptake, and enhances fatty
acid oxidation by phosphorylating and inactivating acetyl-coenzyme A
carboxylase (ACC), a key regulator of fatty acid entry into mitochondria
[6–8]. In hypothalamic neurons AMPK behaves as a key signaling mole-
cule mediating the central control of appetite by orexigenic and anorec-
tic hormones [6–8]. By regulating energy metabolism, AMPK may also
control cell survival and exert short-term neuroprotective effects
under conditions of reduced energy supply or hypoxia [9,10].
AMPK is a heterotrimeric complex composed of a catalyticα subunit,
comprising theα1 andα2 isoforms, and regulatory β and γ subunits, of
which two (β1 and β2) and three (γ1–3) isoforms have been identiﬁed,
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Thr172within theα subunit T-loop activation domain mediated by dif-
ferent protein kinases, including the tumor suppressor LKB1, the Ca2+/
calmodulin-dependent protein kinase kinase-β (CaMKK-β) and
transforming growth factor-β-activated kinase 1 [6–8].
It has been demonstrated that AMPK phosphorylation at Thr172
elicited by Gq/11-coupled mAChRs was dependent on CaMKK-β
activity [11–13], which is consistent with the ability of these receptors
to stimulate phospholipase C-β (PLC-β) and to increase intracellular
Ca2+ levels. However, the mechanisms regulating the Ca2+ availability
for CaMKK-β activation following stimulation of mAChRs have not
been yet elucidated. It is known that stimulation of PLC-β by Gq/11-
coupled receptors generates inositol 1,4,5-trisphosphate (InsP3), which
binds to speciﬁc channel/receptors (InsP3Rs) expressed in the endoplas-
mic reticulum to cause an initial Ca2+ release from intracellular stores
[14]. The consequent depletion of Ca2+ stores activates a sustained
entry of extracellular Ca2+ via distinct plasma membrane channels in a
process termed store-operated Ca2+ entry (SOCE) [15]. Thus, one impor-
tant issue is to understand the relative contribution of these distinct Ca2+
pathways to the regulation of AMPK signaling by Gq/11-coupledmAChRs.
The human neuroblastoma SH-SY5Y cell line has been widely
employed as a simple model system where to study Ca2+ signaling by
Gq/11-coupled mAChRs, as this cell line comprises a relatively homoge-
neous population of neural cells predominantly expressingM3 mAChRs
coupled to Ca2+ mobilization [16,17].
In the present study,we provide evidence that in SH-SY5Y cells SOCE
is required for sustained activation of AMPK triggered by M3 mAChRs.
Moreover, we show that in these cells the activation of SOCE-AMPK sig-
naling axis by M3 mAChRs up-regulates glucose uptake.
2. Material and methods
2.1. Material
[γ-32P]ATP (3000 Ci mmol−1) and [3H]2-deoxy-D-glucose
(8.0 Ci mmol−1) were obtained from PerkinElmer Life and Analytical
Sciences. Ionomycin, ω-conotoxin GVIA (Conus geographus), fura-2/
acetoxymethylester (fura-2/AM), fura-2, pluronic acid and 2-deoxy-D-
glucose were from Calbiochem (La Jolla, CA, USA). Muscarinic toxin 7
(MT-7) was from Peptide International (Louisville, KY, USA), whereas
muscarinic toxin 3 (MT3) isolated from the venoms of Dendroaspis
angusticeps was kindly provided by Profs. E. Karlsson and A. Adem
(Karolinska Institute, Stockholm, Sweden). 4-DAMP (1,1-dimethyl-4-
diphenylacetoxypiperidinium iodide) was from Tocris (Avonmouth,
U.K.). Darifenacin hydrobromide was obtained from Santa Cruz Biotech-
nology (Santa Cruz, CA, USA). Thapsigargin, 2-aminoethoxydiphephenyl
borate (2-APB), nifedipine, STO609, KB-R7943, carbachol (CCh), atropine
sulfate, methoctramine hydrate, probenecid, phloretin, cytochalasin B,
and the other reagents were from Sigma-Aldrich (St. Louis, MO, USA).
2.2. Cell culture
SH-SY5Y cells were obtained from the European Cell Culture Collec-
tion (Salisbury, UK) and grown in Ham's F12/MEM medium (1:1) sup-
plemented with 2 mM L-glutamine, 1% non-essential amino acids, 10%
fetal calf serum (FCS) and 100 U ml−1 penicillin–100 μg ml−1 strepto-
mycin (Invitrogen, Carlsbad, CA, USA). Chinese hamster ovary (CHO)
cells stably transfected with the humanM1mAChR (CHO/M1) were ob-
tained and grown as previously described [18].
2.3. Cell treatment and cell sample preparation
Cells were serum-starved for 24 h, washed with phosphate-buffered
saline (PBS) (pH 7.40) and incubated in freshly prepared Krebs-HEPES
(K-H) buffer containing 25 mM Hepes/NaOH (pH 7.4), 125 mM NaCl,
1.2 mM Mg2SO4, 10 mM glucose, 1.2 mM KH2PO4, 3.8 mM KCl and1.2 mM CaCl2 for 20 min at 37 °C. When a Ca2+-free condition was
used, CaCl2 was omitted and 0.1 mM EGTA was added to the buffer.
Free Ca2+ concentrations in the presence of 0.1 mM EGTA were deter-
mined by using fura-2 ﬂuorescence. In the absence of added CaCl2 and
EGTA, the buffer Ca2+ concentration was ~3 μM. Agents were dissolved
in either saline or dimethyl sulfoxide (DMSO). The ﬁnal DMSO concentra-
tionwas equal to or less than 0.5%. Control sampleswere incubated in the
presence of an equal concentration of vehicle. After treatments, cells were
washedwith ice-cold PBS and cell extractswere prepared by scraping the
cells in an ice-cold RIPA buffer containing PBS, 0.1% SDS, 1% Nonidet P-40,
0.5% sodiumdeoxycholate, 2mMEDTA, 2mMEGTA, 4mM sodiumpyro-
phosphate, 2 mM sodium orthovanadate, 10mM sodium ﬂuoride, 20 nM
okadaic acid, 1% phosphatase inhibitor cocktail 3, 1% protease inhibitor
cocktail and 1 mM phenylmethylsulfonyl ﬂuoride (PMSF). The samples
were sonicated for 5 s in ice-bath and aliquots were taken for protein
determination by the Bio-Rad protein assay (Bio-Rad Lab, Hercules,
CA, USA). Aliquots containing equal amount of protein were mixed
with sample buffer and subjected to SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE).
2.4. Small interfering RNA (siRNA) transfections
SH-SY5Y cells were transfected with either control siRNA-A, human
stromal interactionmolecule 1 (STIM1) siRNA (Santa Cruz Biotechnolo-
gy), human M3 mAChR Silencer® Select siRNA or Silencer® negative
control (Ambion/Life Technologies, Monza, Italy) using Lipofectamine
2000 (Invitrogen/Life Technologies) as transfection reagent. Cells
grown in either 6-well plates or glass coverslips were incubated in
antibiotic-free medium for 24 h. The medium was substituted with
Opti-MEM I reduced serum medium (Invitrogen/Life Technologies)
and the cells were incubated with siRNA duplexes (100 nM) for 12 h
at 37 °C. When M3 mAChR siRNA was used, cells were transfected
twice with 24 h time interval. Cells were analyzed 48 h post-
transfection. To determine transfection efﬁciency, parallel samples
were treated with ﬂuorescein-conjugated control siRNA-A (Santa Cruz
Biotechnology). An efﬁciency of ~63% was obtained in ten separate
experiments.
2.5. Adenoviral infections
SH-SY5Y cells were seeded at the density of 1 × 105 cells/well
24 h before infection. Thereafter, the medium was removed and
changed to a fresh medium containing 2% FCS. Cells were infected
with 50 plaque forming units/cell of either null control recombinant
adenovirus (ADV) or dominant-negative (DN) AMPKα1 recombi-
nant ADV (Eton Bioscience, San Diego, CA, USA) for 12 h. The DNmu-
tant contains a D159Amutation in the ATP binding domain and lacks
the ATP binding capacity. The mutant competes with wild type
AMPKα1 for the binding to β and γ subunits [19]. Cells were then
transferred to normal growth medium, serum-starved overnight,
and analyzed 48 h post-infection.
2.6. Assay of AMPK activity
AMPK activity was assayed following immunoprecipitation by using
a site speciﬁc peptide corresponding to the Ser79 phosphorylation site
of ACC (SAMS peptide) as substrate. Following treatment, cells were
washed with ice-cold PBS and scraped in an ice-cold lysis buffer con-
taining 20mMTris–HCl (pH 7.0), 50mMNaCl, 5mMsodiumpyrophos-
phate, 50 mM NaF, 2 mM dithiothreitol (DTT), 0.25 M sucrose, 1%
Nonidet P-40, 1% protease inhibitor cocktail, 0.5% phosphatase inhibitor
cocktail 3, 2mMsodiumorthovanadate and 1mMPMSF. The lysatewas
centrifuged at 20,800 g for 5 min at 4 °C and the supernatant was col-
lected and assayed for protein content. Aliquots containing equal
amount of protein (500–600 μg) were incubated with 1.5 μg of anti-
AMPKα1/2 subunit antibody (Santa Cruz Biotechnology) for 2 h at
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agarose slurry were added and the incubation was continued for 1 h at
4 °C. The beads were washed three times with a washing buffer con-
taining 20 mM Tris–HCl (pH 7.4), NaCl 140 mM, 1% Nonidet P-40 and
1 mM DTT and once with assay buffer containing 40 mM Hepes/NaOH
(pH 7.0), 80 mM NaCl, 8% glycerol, 0.8 mM EDTA, 0.8 mM DTT, 5 mM
MgCl2 and 200 μM AMP. Beads were ﬁnally resuspended in 20 μl of
assay mixture containing assay buffer supplemented with 50 μM ATP,200 μM SAMS peptide and 3 μCi of [γ-32P]ATP and incubated for
15 min at 30 °C. Blanks were prepared by omitting the SAMS peptide.
Reaction was stopped by adding EDTA (ﬁnal concentration 90 mM)
and centrifuging at 8000 g for 2 min at 4 °C. An aliquot of the superna-
tant was spotted onto Whatman P81 phosphocellulose paper strip,
whichwas air dried andwashedwith 1% phosphoric acid. The 32P radio-
activity absorbed onto the P81 strips was measured by scintillation
counting. Assays were run in triplicates.
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Cells were serum-starved for 24 h and incubated with the experi-
mental agents as indicated in the ﬁgure legends. Thereafter, cells were
washed with PBS and lysed with ice-cold RIPA buffer supplemented
with 0.5% Triton X 100. Following incubation for 30 min at 4 °C, cell ly-
sates were centrifuged at 10,000 g for 10 min at 4 °C. The supernatants
(~700 μg of protein) were incubated overnight at 4 °C with either anti-
Orai1 (3 μg), anti-transient receptor potential canonical 1 (TRPC1)
(2 μg) antibodies or pre-immune IgG (3 μg) (Santa Cruz Biotechnology).
Thereafter, 30 μl of protein G Plus/protein A agarose suspension
(Calbiochem) were added and samples were incubated at 4 °C for 3 h
with continuous rotation. The samples were centrifuged at 8000 g for
5 min and the beads were washed 5 times with ice-cold RIPA buffer.
After the last wash, the pellet was resuspended in 2× sample buffer
and boiled for 5 min.
2.8. Western blot analysis
Cell proteins were applied onto either 10% or 4–12% NuPAGE gels
(Invitrogen/Life Technologies), separated by SDS-PAGE, and electropho-
retically transferred to either polyvinylidene diﬂuoride (Immobilon-P,
Millipore, Temecula, CA, USA) or nitrocellulose (Hybond-ECL;
Amersham Biosciences, Piscataway, NJ, USA) membranes. Membranes
were blocked and incubated overnight at 4 °C with one of the following
primary antibodies: anti-phospho-AMPKα (Thr172) (1:2000), anti-
STIM1 (1:1000), anti-extracellular signal-regulated kinases 1 and 2
(ERK1/2) (1:2000) (Cell Signaling Technology, Beverly, MA, USA);
anti-phospho-ACC (Ser79) (1:500) (Millipore); anti-phospho-ERK1
(Thr202/Tyr204)/ERK2 (Thr185/Tyr187) (1:15,000) (Neuromics,
Northﬁeld, MN, USA); anti-AMPKα1/2 (1:1000), anti-Orai1 (1:1000),
anti-ACC (1:500), anti-TRPC1 (1:1000) (Santa Cruz Biotechnology);
anti-M3 mAChR (1:500) (Alomone Labs, Jerusalem, Israel); and anti-
actin (1:2000) (Sigma-Aldrich). Membranes were then washed and in-
cubated with an appropriate horseradish peroxidase-conjugated sec-
ondary antibody (Santa Cruz Biotechnology). Immunoreactive bands
were detected using ECL-Plus reagent and ECL Hyperﬁlm (Amersham).
Band densities were analyzed using Image Scanner III (GE Healthcare,
Milan, Italy) and NIH ImageJ software (US NIH, Bethesda, MA, USA).
The optical density of phosphoprotein bands was normalized to the
density of the corresponding total protein, whereas the optical density
of non-phosphorylated protein was normalized to that of actin or the
indicated reference protein.
2.9. Immunoﬂuorescence analysis
Cells grown onto poly-L-lysine-coated coverslips and serum-
starved were incubated in Ca2+-free K-H buffer in the presence of ei-
ther 10 μM CCh for 4 min or 2 μM thapsigargin for 20 min at 37 °C.
Control samples were treated with vehicle. Cells were ﬁxed in 4%
paraformaldehyde at 37 °C, permeabilized with 0.2% Triton X 100Fig. 1.M3mAChRsmediate AMPK activation in SH-SY5Y cells. (A) Concentration-dependent stim
5 min with the indicated concentrations of CCh and the levels of phosphorylated AMPKα (pAM
experiments. (B) Concentration-dependent stimulation of ACC phosphorylation at Ser79 by CCh
termined in cell extracts. Values are themean±SEMof four experiments. (C) Lack of effect ofMT
vehicle or the indicated concentrations of MT-7 and then exposed for 5 min to either vehicle or 1
AMPK phosphorylation by MT-7 in CHO/M1 cells. Serum-starved cells were pre-incubated for 1
CCh. Values are the mean ± SEM of three experiments. (E) Effects of methoctramine (methoctr
vehicle or the indicated concentrations of methoctramine and then exposed for 5 min to either v
dependent inhibition of CCh-inducedAMPK phosphorylation by darifenacin (darifen). Cells were
and then exposed for 5 min to either vehicle or 10 μM CCh. Values are the mean ± SEM of thre
lation by 4-DAMP. Cells were pre-incubated for 10minwith either vehicle or the indicated conce
themean±SEMof three experiments. (H) Effects ofMT3 on CCh-inducedAMPKphosphorylatio
MT3 and then exposed for 5min to either vehicle or 10 μMCCh.Values are themean±SEMof th
with either control or M3 mAChR siRNA. Cells were transfected and analyzed as described unde
three. Themigration of molecularmass standard is indicated by the arrows. (J) Knockdown ofM
trol or M3 siRNA and exposed for 5 min to either vehicle or CCh (0.3 μM) 48 h post-transfectio
percent of control (control siRNA + vehicle) and are the mean ± SEM of three experiments. **and blocked with 3% bovine serum albumin (BSA) plus 1% normal
goat serum. Cells were then incubated overnight at 4 °C with anti-
STIM1 antibody (1:800) (Cell Signaling Technology) followed by in-
cubation with Alexa 488-conjugated goat anti-rabbit IgG (1:3000)
(Molecular Probes) and 0.1 μg ml−1 4′,6-diamidino-2phenylindole
dihydrochloride (DAPI) (Sigma-Aldrich). Control samples were in-
cubated in the absence of primary antibody. Cells were mounted in
Gel Mount aqueous mounting medium (Sigma-Aldrich) and exam-
ined by using an Olympus BX61 microscope and an Olympus
Fwiew charge-coupled device camera. Images were captured with a
60× oil-immersion objective and mirror units for the detection of
green ﬂuorescence (U-MNIBA3: excitation 470–495, emission 510–
550) and blue ﬂuorescence (U-MNUA2, excitation 360–370, emis-
sion 420–460) and arranged using the program Cell P (Olympus
Soft Imaging Solutions). Four separate cell culture preparations
were analyzed.
2.10. Measurement of intracellular free Ca2+ concentration
in cell population
Intracellular free Ca2+ concentration ([Ca2+]i) was measured in
sub-conﬂuent monolayers of SH-SY5Y cells using the Ca2+ sensitive
dye fura-2 as previously described [13]. Cells were grown onto poly-L-
lysine-coated 10 mm diameter round glass coverslips individually
placed into the wells of 24-well plates. The cells were incubated in the
presence of 5 μM fura-2/AM, 0.05% BSA and 0.15% (v/v) pluronic acid
for 1 h at 37 °C in serum-free growing medium containing 1 mM pro-
benecid. Thereafter the cells were washed three times with K-H buffer
and kept at room temperature with the same buffer without added
CaCl2. Each coverslip was ﬁxed to a coverslip holder (PerkinElmer,
Beaconsﬁeld, UK) and transferred to a quartz cuvette. The cuvette was
placed in a Perkin-Elmer LS-50B ﬂuorimeter equipped with a thermo-
static chamber set at 37 °C and operated through a computer program
by using the FL Winlab software (PerkinElmer). Test agents were
injected into the bathingmedium under continuous stirring at the indi-
cated time points. The samples were alternatively excited at 340 and
380 nm and the emission was recorded at 510 nm. Data were acquired
every 1.9 s. [Ca2+]i was calculated using FLWinlab software assuming a
fura-2 Kd value for Ca2+ of 224 nM. Maximum (Rmax) and minimum
(Rmin) emission values were determined by adding the Ca2+ ionophore
ionomycin (20 μM) with 10 mM CaCl2 followed by 0.2% Triton X 100
and 15 mM EGTA (pH adjusted to 10 with Tris base), respectively.
Autoﬂuorescence was measured in parallel samples unloaded with
fura-2/AM.
2.11. Assay of glucose uptake
Measurement of 2-deoxy-D-glucose uptake was performed accord-
ing to previously described procedure [20]. Unless otherwise speciﬁed,
serum-starved cells were washed and incubated with K-H buffer with-
out D-glucose for 20 min at 37 °C. CCh was then added and theulation of AMPKphosphorylation at Thr172 byCCh. Serum-starved cellswere incubated for
PK) and total AMPKαwere determined in cell extracts. Values are themean± SEM of four
. Cells were treated as in (A) and the levels of phospho-ACC (pACC) and total ACC were de-
-7 on CCh-inducedAMPKphosphorylation. Cellswere pre-incubated for 10minwith either
0 μMCCh. Values are themean± SEM of three experiments. (D) Blockade of CCh-induced
0 min with either vehicle or 10 nMMT-7 and then treated with either vehicle or 100 μM
) on CCh-induced AMPK phosphorylation. Cells were pre-incubated for 10 min with either
ehicle or 10 μMCCh. Values are themean± SEM of three experiments. (F) Concentration-
pre-incubated for 10minwith either vehicle or the indicated concentrations of darifenacin
e experiments. (G) Concentration-dependent inhibition of CCh-induced AMPK phosphory-
ntrations of 4-DAMP and then exposed for 5min to either vehicle or 10 μMCCh. Values are
n. Cellswere pre-incubated for 10minwith either vehicle or the indicated concentrations of
ree experiments. (I)Western blot analysis ofM3mAChRexpression in SH-SY5Y cells treated
r Material and methods section. Immunoblots are from one experiment representative of
3 mAChRs inhibits CCh-induced AMPK phosphorylation. Cells were treatedwith either con-
n. Cell lysates were analyzed for phospho-AMPK and total AMPK. Values are expressed as
*P b 0.001 vs vehicle; ###P b 0.001 by ANOVA followed by Newman–Keuls post hoc test.
Fig. 2. Sustained AMPK activation by M3 mAChRs requires extracellular Ca2+. (A) [Ca2+]i
was measured in fura-2/AM-loaded cells stimulated with 10 μM CCh in either Ca2+-free
medium or in the presence of 1.2 mM extracellular Ca2+. Data are from a single experi-
ment representative of ten similar experiments. (B and C) Cells grown in individual
35 mm Petri dishes were treated for the indicated time periods with CCh (10 μM) in the
presence (B) and in the absence (C) of 1.2 mM extracellular Ca2+. AMPK phosphorylation
at Thr172wasmeasured in cell lysates byWestern blot and normalized to the level of total
AMPK. (D) Values of CCh-induced AMPK phosphorylation in the presence and in the
absence of extracellular Ca2+ are expressed as percent of the corresponding control
(0 time) and are the mean ± SEM of ﬁve experiments. ***P b 0.001, *P b 0.05 vs 0
time value (vehicle-treated cells).
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5 min before the agonist. Control samples received an equal volume of
vehicle. The reaction was started by adding [3H]2-deoxy-D-glucose
(1 μCi ml−1) together with 1 mM unlabelled 2-deoxy-D-glucose and
was continued for 8 min. The incubation was stopped by aspirating
the medium and washing the cells with ice-cold K-H buffer containing
10 mM D-glucose and 0.2 mM phloretin. Cells were solubilized and ra-
dioactivity was measured by liquid scintillation counting. Nonspeciﬁc
uptakewas determined by adding 20 μMcytochalasin B to parallel sam-
ples and this value was subtracted from that of each experimental sam-
ple. Assays were run in triplicate.
2.12. Statistical analysis
Results are reported as mean ± SEM of n independent experi-
ments. Concentration–response curves were analyzed by GraphPad
Prism (San Diego, CA, USA). For statistical analysis the EC50 values
were converted to the logarithmic form (pEC50) as they are log-
normally distributed. Antagonist inhibition constant (Ki) was deter-
mined according to the equation: Ki = IC50 / 1 + (A / EC50), where
IC50 is the antagonist concentration producing half-maximal inhibi-
tion, A is the agonist concentration, and EC50 is the agonist EC50
value. Ki values were converted to the logarithmic form (pKi).
Traces of [Ca2+]i were from a single experiment, whichwas repeated
with similar results in at least four separate experiments. To quantify
changes in [Ca2+]i, in each calibrated trace CCh-induced peak was mea-
sured as the difference between themaximal and basal values, whereas
CCh-induced [Ca2+]i plateau was determined as the area under the
curve following the peak by using GraphPad Prism. Statistical analysis
was performed by either Student's unpaired t test or one-way analysis
of variance (ANOVA) followed by Newman–Keuls post hoc test as
appropriate.
3. Results
3.1. mAChR-induced AMPK regulation is mediated by the M3 subtype
Although SH-SY5Y cells are commonly considered to express a ho-
mogeneous population of M3mAChRs, no study has so far characterized
the mAChR subtype(s) regulating AMPK in these cells. As shown in
Fig. 1A, the cholinergic agonist CCh elicited a concentration-
dependent increase of AMPK phosphorylation at Thr172 with a
pEC50 value of 5.88 ± 0.09 and a maximal effect corresponding to
3–4-fold increase of control value (P b 0.001, n = 4). In the same
cell preparations, CCh induced a marked enhancement in the levels
of phosphorylated ACC, a major substrate of AMPK, with a pEC50 of
5.63 ± 0.15 (Fig. 1B). This value was not statistically different from
that obtained in stimulating AMPK phosphorylation. As shown in
Fig. 1C, cell treatment with the selective M1 antagonist MT-7 [21]
failed to block CCh-stimulation of AMPK phosphorylation. As a con-
trol, we examined MT-7 effect in CHO/M1 cells. In these cells MT-7
(10 nM) completely prevented AMPK phosphorylation induced by
CCh (100 μM) (Fig. 1D). CCh-induced stimulation of AMPK phos-
phorylation was also insensitive to the M2-preferring antagonist
methoctramine (Fig. 1E). The M3-preferring antagonist darifenacin
and 4-DAMP, which has an afﬁnity for M1, M3, M4 and M5 higher than
that forM2mAChRs [22], completely blocked CCh-induced AMPK phos-
phorylationwith pKi values of 9.10±0.10 and 9.04± 0.05, respectively
(Fig. 1F and G). Conversely, MT3, which selectively blocks the M4 sub-
type [23], failed to antagonize the CCh stimulatory effect (Fig. 1H). We
further analyzed the involvement of M3 mAChRs by knocking down
the receptorswith speciﬁc siRNA. As shown in Fig. 1I,Western blot anal-
ysis of M3 mAChR expression in SH-SY5Y cells revealed the presence of
three major immunoreactive bands of 70, 90–110 and 220 kDa. The
bandswithmolecularmass of 90–110 and 220 kDa likely represent gly-
cosylated and dimeric/oligomeric forms of the receptor [24]. Treatmentof SH-SY5Y cells withM3mAChR siRNA decreased the expression of the
70, 90–110 and 220 kDa immunoreactive bands by 50 ± 8, 62 ± 9 and
68 ± 12%, respectively (n = 3, P b 0.05), when compared to control
siRNA-treated cells. In M3 mAChR-depleted cells the stimulation of
AMPK phosphorylation by a submaximal concentration of CCh
(0.3 μM) was completely suppressed (Fig. 1J).
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phosphorylation by mAChR
To investigate the involvement of Ca2+ entry in AMPK regulation,
we ﬁrst examined the dependence of this response on extracellular
Ca2+. In agreement with previous studies [17,25–27], in fura-2 loaded
cells CCh (10 μM) evoked a rapid [Ca2+]i peak within 7–10 s, which re-
ﬂects Ca2+ mobilization from intracellular stores, and a subsequent
prolonged plateau, which depends on Ca2+ inﬂux (Fig. 2A). As expect-
ed, in the absence of extracellular Ca2+, the cholinergic agonist still in-
duced a robust [Ca2+]i peak but the [Ca2+]i plateau was suppressed.
When AMPK was examined, it was found that in the presence of
1.2 mM extracellular Ca2+ CCh (10 μM) induced a rapid increase of
phospho-Thr172 AMPK, which reached a peak at 1 min andmaintained
this level for at least 3min (Fig. 2B, D). On the other hand, in the absence
of extracellular Ca2+ CCh (10 μM) induced a transient increase of AMPK
phosphorylation, which peaked at 20 s and rapidly declined to reach
basal levels at 2 min (Fig. 2C, D).Fig. 3. Reversal of CCh-induced AMPK phosphorylation by either extracellular Ca2+ removal orm
the levels of phospho-AMPK and phospho-ACCwere then determined in cell lysates byWestern
SEMof four experiments. ***P b 0.001 vs 0 time. (B) [Ca2+]i wasmeasured in fura-2/AM-loaded
EGTAwas added. Data are from a single experiment and are representative ofﬁve similar experi
30 min (veh 30′; CCh 30′). In a separate set of samples 4 mM EGTA was added to cells treated f
continued for 25 min. Values of AMPK phosphorylation are expressed as percent of control (ve
responding vehicle-treated value, ###P b 0.001 by ANOVA followed by Newman–Keuls post ho
the time indicated by the arrow either vehicle or 100 nM atropinewas added. Data are from a si
with either vehicle (veh) or 10 μM CCh for 5 min (CCh 5′) or 30 min (CCh 30′). In a separate se
continued for 5min (atrop+ CCh 5′) or following 5min treatment with either vehicle (veh+ a
phosphorylation are expressed as percent of control (vehicle-treated cells) and are themean±
man–Keuls post hoc test.Kinetic analysis at longer time intervals showed that in the presence
of extracellular Ca2+ the increase of AMPK phosphorylation elicited
by CCh lasted for at least 180 min (Fig. 3A), indicating a sustained ac-
tivation following mAChR stimulation. A similar kinetic proﬁle was
observed examining CCh-induced ACC phosphorylation (Fig. 3A). In
fura-2-loaded cells stimulated by CCh (10 μM), addition of EGTA
(4 mM) to bind extracellular Ca2+ suppressed [Ca2+]i plateau
(Fig. 3B). When AMPK phosphorylation was examined under a sim-
ilar protocol, the addition of EGTA to cells pre-treated with CCh
(10 μM) for 5 min, a time sufﬁcient to allow maximal AMPK phos-
phorylation, brought phospho-Thr172 AMPK to control levels
(Fig. 3C). Collectively, these data indicate that the sustained AMPK
phosphorylation induced by CCh required the inﬂux of extracellular
Ca2+.
Previous studies have shown that in SH-SY5Y cells the mAChR-
induced [Ca2+]i plateau requires the continued presence of the agonist
[26,28]. Accordingly, addition of atropine (100 nM) to cells pre-treated
with CCh (10 μM) induced a drop of [Ca2+]i plateau to resting levelsAChR blockade. (A) Cellswere exposed for the indicated periods of time to 10 μMCCh and
blot. Values are expressed as percent of 0 time (vehicle-treated cells) and are themean±
cells stimulatedwith 10 μMCCh. At the time indicated by the arroweither vehicle or 4mM
ments. (C) Cells were treatedwith vehicle or 10 μMCCh for either 5min (veh 5′; CCh 5′) or
or 5 min with either vehicle (veh+ EGTA) or CCh (CCh+ EGTA) and the incubation was
hicle-treated cells) and are the mean ± SEM of four experiments. ***P b 0.001 vs the cor-
c test. (D) [Ca2+]i was measured in fura-2/AM-loaded cells stimulated with 10 μM CCh. At
ngle experiment and are representative of four similar experiments. (E) Cells were treated
t of samples 100 nM atropine was added either 1 min before CCh and the incubation was
trop) or CCh (CCh+ atrop) and the incubationwas continued for 25min. Values of AMPK
SEMofﬁve experiments. ***P b 0.001 vs vehicle, ###P b 0.001 byANOVA followed byNew-
Fig. 4. Inhibition of CCh-stimulated AMPK phosphorylation by 2-APB and lack of effect by VOCs and reverse mode Na+/Ca2+ exchange inhibitors. (A) [Ca2+]i was measured in
cells pre-treated for 4 min with either vehicle or 50 μM 2-APB and then stimulated with 10 μM CCh. Data are from a single experiment and are representative of ﬁve similar ex-
periments. (B) Cells were incubated either in the presence (upper panels) or in the absence (lower panels) of 1.2 mM extracellular Ca2+ and pre-treated with either vehicle or
50 μM 2-APB for 4 min. Cells were then exposed to vehicle or 10 μM CCh for either 5 min (upper panels) or 20 s (lower panels). Cell lysates were analyzed for AMPK phosphor-
ylation by Western blot. Values are expressed as percent of control (vehicle-treated cells) and are the mean ± SEM of ﬁve (upper panels) and four (lower panels) experiments.
***P b 0.001 vs vehicle, #P b 0.05 by ANOVA followed by Newman–Keuls post hoc test. (C) [Ca2+]i was measured in cells stimulated with 10 μM CCh. At the time indicated by the
arrow either vehicle or 50 μM 2-APB was added. Data are from a single experiment and are representative of ﬁve similar experiments. (D) Cells were treated with vehicle or
10 μM CCh for either 5 min (veh 5′; CCh 5′) or 30 min (veh 30′; CCh 30′). In a separate set of samples 50 μM 2-APB was added to cells treated for 5 min with either vehicle
(veh + 2-APB) or CCh (CCh + 2-APB) and the incubation was continued for 25 min. Values of AMPK phosphorylation are the mean ± SEM of ﬁve experiments. ***P b 0.001
vs the corresponding vehicle-treated value, ###P b 0.001 by ANOVA followed by Newman–Keuls post hoc test. (E) Cells were pre-incubated for 10 min with either vehicle,
5 μM nifedipine (nife) or 100 nM ω-conotoxin GVIA (ω-cono) and then exposed for 5 min to either vehicle or 10 μM CCh. Values of AMPK phosphorylation are the mean ±
SEM of three experiments. ***P b 0.001 vs vehicle. (F) Cells were pre-incubated for 10 min with either vehicle or 10 μM KB-R7943 and then exposed for 5 min to either vehicle
or 10 μM CCh. Values are the mean ± SEM of three experiments. ***P b 0.001 vs vehicle.
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Fig. 5. Involvement of STIM1 inmAChR stimulation of AMPKphosphorylation. (A) Cellswere transfectedwith either control siRNA or STIM1 siRNA and cell lysateswere analyzed for STIM1
and actin levels 48 h after transfection. Each lane represents a separate experiment. (B) [Ca2+]i wasmeasured in cells pre-treatedwith either control siRNA or STIM1 siRNA and then stim-
ulatedwith 10 μMCCh. Data are from a single experiment and are representative of four similar experiments. (C) Cells pre-treatedwith either control siRNA or STIM1 siRNAwere exposed
to 10 μMCCh for the indicated periods of time. The levels of STIM1 expression and AMPK phosphorylationwere determined in cell lysates byWestern blot. Values are expressed as percent
of control (control siRNA+ vehicle) and are the mean ± SEM of ﬁve experiments. ***P b 0.001 vs control, #P b 0.05 by ANOVA followed by Newman–Keuls post hoc test. (D) Cells were
pre-treated as in (C) and then exposed to either vehicle or CCh (10 μM) for 5min. The levels of phospho-ACC and total ACCwere determined in cell lysates. Values are themean± SEM of
four experiments. ***P b 0.001 vs control (control siRNA+ vehicle), ###P b 0.001 by ANOVA followed by Newman–Keuls post hoc test. (E) Cells were treated as in (D) and AMPK activity
was determined in immunoprecipitates as described under Material andmethods. Values are expressed as percent of control (control siRNA+ vehicle) and are the mean ± SEM of four
experiments. ***P b 0.001 vs control, #P b 0.05 by ANOVA followed by Newman–Keuls post hoc test. (F) Cells were treated as in (C) and the levels phospho-ERK1/2 and total ERK were
determined in cell lysates by Western blot.
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AMPK phosphorylation when added before the agonist, but also
completely reversed the stimulatory response when added after CCh(Fig. 3E). Thus, continuous receptor occupancy by the muscarinic ago-
nist was necessary to sustain both [Ca2+]i plateau and AMPK
phosphorylation.
Fig. 6. Immunoﬂuorescence analysis of STIM1 puncta formation. Serum-starved cells were incubated in Ca2+-free medium at 37 °C and exposed to either 10 μM CCh for 4 min or 2 μM
thapsigargin for 20min. Control samples were treated with vehicle. Cells were then stained with an anti-STIM1 antibody (green ﬂuorescence). Nuclei were stained with DAPI (blue ﬂuo-
rescence). Noprimary are cells incubated in the absence of anti-STIM1 antibody. Bar = 25 μm. Data are representative of three similar experiments.
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2-APB has been widely used as pharmacological tool to study SOCE in
different cell systems. This compound has been found to enhance Ca2+
release-activated Ca2+ currents at low micromolar concentrations and
to inhibit them at higher concentrations [29,30]. Moreover, 2-APB has
been shown to block cationic currents through different transient recep-
tor potential (TRP) channels, including TRPC channels [31]. In SH-SY5Y
cells, pre-treatment with 2-APB, at a concentration (50 μM) reported to
block SOCE [30,31], caused a slight reduction of CCh (10 μM)-induced
[Ca2+]i peak and markedly depressed the subsequent [Ca2+]i plateau
(Fig. 4A).Western blot analysis showed that in the presence of extracellu-
lar Ca2+ (1.2 mM) cell pre-treatment with 2-APB (50 μM) caused amod-
est and not signiﬁcant increase of basal AMPK phosphorylation, but
signiﬁcantly inhibited the stimulation induced by 5 min treatment with
CCh (10 μM) (Fig. 4B). On the other hand, in the absence of extracellular
Ca2+, the stimulation of AMPK phosphorylation elicited by a brief (20 s)
exposure to CCh was not affected by pre-treatment with 2-APB
(Fig. 4B). When added after CCh, 2-APB (50 μM) caused a sustained de-
crease of [Ca2+]i plateau levels in fura-2 loaded cells (Fig. 4C) and a signif-
icant reversal of CCh-induced AMPK phosphorylation (Fig. 4D).
SH-SY5Y neuroblastoma cells express voltage-gated Ca2+ channels
(VOCs) [32,33], and there is evidence that in these cells mAChR stimula-
tion induces membrane depolarization [34]. However, neither nifedi-
pine (5 μM) nor ω-conotoxin GVIA (100 nM), which block L-type and
N-type VOCs, respectively, affected the stimulatory effect of CCh on
AMPK phosphorylation (Fig. 4E).Na+/Ca2+ exchange acting in reverse mode constitutes another
route of extracellular Ca2+ inﬂux under conditions of membrane depo-
larization and localized increases of intracellular Na+. Cell treatment
with KB-R7943 (10 μM), a relatively selective inhibitor of reverse
mode Na+/Ca2+ exchange, had no signiﬁcant effect on CCh-induced
AMPK phosphorylation (Fig. 4F).3.4. Involvement of STIM1 in mAChR-induced AMPK stimulation
STIM1 and 2 proteins have been identiﬁed as molecular triggers of
SOCE activation [35–37]. Within the endoplasmic reticulum STIM pro-
teins behave as sensors of luminal Ca2+ levels and upon Ca2+ depletion
translocate to specialized junctions between the endoplasmic reticulum
and the plasma membrane where they activate Orai channels [38,39].
We investigated the involvement of STIM1 in mAChR regulation of
AMPK phosphorylation by knocking down STIM1 expression. Cell treat-
ment with STIM1 siRNA reduced STIM1 protein levels by 78 ± 7%
(P b 0.001), as compared to control siRNA-treated cells (Fig. 5A). Anal-
ysis of [Ca2+]i showed that STIM1 siRNA treatment reduced the CCh-
induced [Ca2+]i plateau phase by 55 ± 8% (P b 0.05, n = 5) (Fig. 5B).
In STIM1-depleted cells, there was a signiﬁcant reduction in the stimu-
lation of AMPK activity by CCh (10 μM) after either 5 or 30min of treat-
ment (Fig. 5C). Similarly, ACC phosphorylation induced by CCh was
signiﬁcantly reduced following STIM1knockdown (Fig. 5D). Conversely,
CCh-induced stimulation of ERK1/2 phosphorylation was not signiﬁ-
cantly affected by STIM1 depletion (Fig. 5E).
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tion can be visualized by its redistribution into puncta localized near
the plasma membrane [40]. In vehicle-treated SH-SY5Y cells STIM1 im-
munoreactivity was generally weak and predominantly distributed in
the perinuclear region (Fig. 6). Conversely, in cells treated for 4 min
with 10 μMCCh STIM1 immunoreactivity appeared as clustered in high-
ly ﬂuorescent puncta with a wider distribution in the cell soma. STIM1
puncta formation induced by CCh was mimicked by cell treatment
with thapsigargin (2 μM), which depletes Ca2+ stores by blocking the
sarco- and endoplasmic reticulum Ca2+-ATPase (SERCA) (Fig. 6).
To assess whether mAChR activation promoted STIM1–Orai interac-
tion, cells were treatedwith CCh (10 μM) in the absence and in the pres-
ence of atropine (100 nM), cell extracts were immunoprecipitated with
an anti-Orai1 antibody and immunoprecipitates were analyzed by
Western blot for the presence of STIM1. As shown in Fig. 7A, CCh in-
creased the amount of STIM1 co-immunoprecipitated with Orai1 and
this effect was completely prevented by atropine (100 nM), which per
se had no effect. No STIM1 immunoreactive band was detected in sam-
ples immunoprecipitated with pre-immune IgG (Fig. 7B).
A number of studies have provided evidence that TRPC channels con-
tribute to SOCE [41–43] and that SOCE may occur through the dynamic
assembly of a TRPC1–Orai1–STIM1 complex [44–47]. We found that SH-
SY5Y cell treatment with CCh (10 μM) increased the amount of TRPC1
immunoprecipitated with anti-Orai1 antibody (Fig. 7C). On the otherFig. 7.mAChR stimulation induces STIM1–Orai1 and TRPC1–Orai1 interactions. (A) Cells were
vehicle or 10 μMCCh for 5min. Cell lysateswere incubatedwith anti-Orai1 antibody andSTIM1 a
immunoreactivity in immunoprecipitates (IP) was normalized to that present in cell lysates. V
*P b 0.05 vs control (vehicle), #P b 0.05 by ANOVA followed by Newman–Keuls post hoc test. (
subjected to immunoprecipitationwith pre-immune IgG. Immunoprecipitates and cell lysatesw
of sample pair (vehicle and CCh) from two independent experiments. (C) Cells were treatedwit
antibody. Immunoprecipitates and cell lysates were analyzed for TRPC1 and Orai1 immunoreact
lysates. Values are expressed as percent of control and are the mean ± SEM of three experime
(A) and cell lysates were immunoprecipitated with anti-TRPC1 antibody. Immunoprecipitat
shows immunoblots of sample pair (vehicle and CCh) from two independent experiments andhand, little or no STIM1 was immunoprecipitated with anti-TRPC1 anti-
body and no difference was observed between samples treated with ei-
ther vehicle or CCh (10 μM) (Fig. 7D).
3.5. Activation of mAChRs stimulates glucose uptake
A short-time exposure (15 min) of SH-SY5Y cells to CCh (100 μM)
elicited a signiﬁcant increase of [3H]-2-deoxy-D-glucose uptake as com-
pared to basal values (Fig. 8A). Cell pre-treatment with either cytocha-
lasin B (20 μM) or phloretin (200 μM), two inhibitors of glucose
transporters of the GLUT family, reduced basal [3H]-2-deoxy-D-glucose
uptake by approximately 72 and 75%, respectively, and completely
blocked the stimulatory effect of CCh (Fig. 8A). The amount of radioac-
tivity incorporated in the presence of cytochalasin B (20 μM)was there-
fore considered as due to a nonspeciﬁc [3H]-2-deoxy-D-glucose inﬂux
and, in each experiment, was subtracted from the experimental values.
As shown in Fig. 8B, CCh-induced [3H]-2-deoxy-D-glucose uptake was
concentration-dependent and saturable with a maximal effect corre-
sponding to 75 ± 7% increase of basal value (P b 0.001, n = 5) and
pEC50 value of 5.64 ± 0.2. This value was not statistically different
from pEC50 values displayed by CCh in stimulating the phosphorylation
of either AMPK or ACC. The stimulation of [3H]-2-deoxy-D-glucose up-
take by CCh (100 μM) was completely blocked by 4-DAMP (1 μM), but
was unaffected by MT-7 (30 nM) (Fig. 8C).pre-treated with either vehicle or 100 nM atropine (atrop) for 5 min and then exposed to
ndOrai1 immunoreactivitieswere analyzed in immunoprecipitates and cell lysates. STIM1
alues are expressed as percent of control and are the mean ± SEM of four experiments.
B) Cells were treated with either vehicle or CCh as described in (A) and cell lysates were
ere then analyzed for STIM1 andOrai1 immunoreactivities. The image shows immunoblots
h either vehicle or CCh as in (A) and cell lysateswere immunoprecipitated with anti-Orai1
ivities. The amount of TRPC1 in immunoprecipitateswas normalized to that present in cell
nts. *P b 0.05 vs control (vehicle). (D) Cells were treated with either vehicle or CCh as in
es and cell lysates were analyzed for STIM1 and TRPC1 immunoreactivities. The image
is representative of a total of four experiments.
Fig. 8.M3 mAChRs enhance glucose uptake in SH-SY5Y cells. (A) Cells were incubated in
the presence of either vehicle, 20 μM cytochalasin B (cytoch) or 200 μM phloretin
(phloret) for 10min. Thereafter, either vehicle or CCh (100 μM)was added for 15min. Re-
action was started by the addition of [3H]-2-deoxy-D-glucose and continued for 8 min.
Values are the mean ± SEM of four experiments. ***P b 0.001 vs control.
(B) Concentration-dependent stimulation of 2-deoxy-D-glucose uptake by CCh. Values
are the mean ± SEM of four experiments. (C) Blockade of CCh-induced glucose uptake
by 4-DAMP and lack of effect by MT-7. Cells were incubated in the presence of either ve-
hicle, 0.5 μM 4-DAMP, or 10 nM MT-7 for 5 min and then treated with either vehicle or
100 μM CCh for 15 min. Values are the mean ± SEM of three experiments. ***P b 0.001
vs control, ###P b 0.001 by ANOVA followed by Newman–Keuls post hoc test.
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ment of glucose inﬂux elicited by CCh (Fig. 9A). This response was
also signiﬁcantly reduced by 2-APB (50 μM), which per se had no effect
on basal glucose uptake (Fig. 9B). Moreover, in STIM1 siRNA-treated
cells there was no stimulation of 2-deoxy-D-glucose uptake by CCh,
whereas a signiﬁcant increase was observed in control siRNA-treated
cells (Fig. 9C). STO609 (10 μM), which inhibits CaMKKβ and has been
reported to prevent AMPK stimulation by mAChR [11–13], signiﬁcantly
reduced CCh-stimulated 2-deoxy-D-glucose uptake (Fig. 9D). Com-
pound C (20 μM), a pharmacological inhibitor of AMPK, completely
blocked CCh stimulation of glucose uptake (Fig. 9E). Moreover, in cells
infected with ADV encoding AMPKα1 DN mutant CCh stimulation of
glucose uptake was suppressed, whereas the agonist induced a signiﬁ-
cant increase in null-ADV infected cells (Fig. 9F).4. Discussion
The present study reports for theﬁrst time that in humanneuroblas-
toma cells SOCE is critical for AMPK activation by M3 mAChRs. More-
over, it shows that in these cells stimulation of M3 mAChRs enhances
glucose uptake and that this effect is dependent on the activation of
SOCE–CaMKKβ–AMPK signaling axis.
Radioligand binding and functional studies have proposed that SH-
SY5Y cells possess a homogenous population of M3 mAChRs coupled
to regulation of [Ca2+]i [16,17]. Conversely, other studies concluded
that in these cells PLC-β is mainly regulated by the M1 mAChR subtype
[48,49]. Moreover, studies examining mAChR mRNA by Northern blot
analysis revealed that SH-SY5Y cells, while lacking the M4 and M5 tran-
scripts, displayed levels of M1 and M2 mRNAs higher than that of M3
mRNA [50]. The present study found that CCh-induced AMPK activation
was insensitive to either the M2-preferring antagonist methoctramine,
the M1-selective antagonist MT-7 or the M4-selective antagonist MT3,
but was potently blocked by the M3-preferring antagonist darifenacin
and 4-DAMP, which prefers M1, M3, M4 and M5 over M2. Furthermore,
M3mAChR knockdownwith siRNA curtailed the CCh stimulatory effect.
Taken together, these results indicate that in SH-SY5Y cells themAChRs
coupled to AMPK activation belong to the M3 subtype.
A line of evidence indicates that SOCE is necessary for sustained ac-
tivation of AMPK signaling by M3 mAChRs. First, although in Ca2+-free
medium CCh was capable of inducing a signiﬁcant AMPK phosphoryla-
tion, this responsewas short-lasting as it rapidly declined to basal levels
within 2 min. Under this condition, the kinetics of AMPK activation ap-
pears to closely follow the [Ca2+]i transient induced by CCh in the ab-
sence of extracellular Ca2+. On the other hand, in the presence of
extracellular Ca2+, a fundamental condition for SOCE occurrence, CCh
increased AMPK activity for at least 3 h. This ﬁnding agrees with a pre-
vious study showing a long-lasting AMPK activation following SH-SY5Y
cells exposure to CCh [51]. Secondly, CCh-induced AMPK phosphoryla-
tion was inhibited by the SOCE blocker 2-APB at a concentration that
markedly depressed CCh-induced [Ca2+]i plateau. The dependence of
2-APB inhibition on blockade of Ca2+ entry is supported by the observa-
tion that the compound failed to affect AMPK phosphorylation induced
by CCh in the absence of extracellular Ca2+, which was likely due to in-
tracellular Ca2+ release. Third, interruption of Ca2+ inﬂux during the
plateau phase by either complexing extracellular Ca2+ with EGTA,
disrupting agonist signaling with atropine, or blocking Ca2+ inﬂux
with 2-APB caused a complete drop of CCh-stimulated phospho-AMPK
levels. Fourth, CCh-induced AMPK activation was dependent on STIM1
expression. mAChR stimulation evoked STIM1 activation, as indicated
by the induction of STIM1 puncta formation, and promoted STIM1–
Orai1 interaction. Down-regulation of STIM1 by siRNA was associated
with inhibition of CCh-induced [Ca2+]i plateau and suppression of
CCh-stimulated AMPK phosphorylation.
TRPC channels are a family of non-selective cationic channels en-
abling the entry of Ca2+ and Na+ into the cells [42,43]. There are
seven members of this family, which have been shown to assemble as
homomers and heteromers. Although there is evidence that TRPC1
forms channels insensitive to store depletion [52], several studies have
shown that TRPC1 is a molecular component of SOCE [41–43] and con-
tributes to the formation of a ternary complex with STIM1 and Orai1
[44–47]. In particular, it has been reported that the STIM1–Orai–
TRPC1 interaction confers store-depletion sensitivity to TRPC channels
[53,54]. In the present study, we found that acute CCh treatment in-
creased the amount of TRPC1 co-immunoprecipitated with Orai1, sug-
gesting that mAChR activation promoted the interaction between the
two channel proteins. The ability of mAChRs to regulate the association
between themolecular components of the SOCEmachinerywas further
investigated by examining the occurrence of a STIM1–TRPC1 interac-
tion. It has been reported that upon Ca2+ store depletion with the com-
bination of thapsigargin and the Ca2+ ionophore ionomycin STIM1–
TRPC1 interaction occurs in cells endogenously expressing the two
Fig. 9. Involvement of SOCE–CaMKKβ–AMPK pathway in glucose uptake stimulation byM3mAChRs. (A) Requirement of extracellular Ca2+ formAChR-induced glucose uptake. Cellswere
incubated in either Ca2+-free K-H buffer (no Ca2+) or in the same buffer containing 1.2 mM Ca2+ followed by the addition of either vehicle or 100 μMCCh. Values are themean± SEM of
three experiments. (B) Inhibition of mAChR-induced glucose uptake by 2-APB. Cells were treatedwith either vehicle or 50 μM2-APB for 5min and thenwere exposed to either vehicle or
100 μMCCh.Values are themean±SEMof four experiments. (C) Cellswere treatedwith either control siRNAor STIM1 siRNA, eachat the concentration of 50nM, and after 48h exposed to
either vehicle or 100 μMCCh. Values are themean± SEMof three experiments. (D) Blockade of mAChR-induced glucose uptake by the CaMKKβ inhibitor STO609. Cells were treated
for 30 min with either vehicle or 10 μM STO609 and then exposed to either vehicle or 100 μM CCh. Values are the mean ± SEM of three experiments. (E) Inhibition of mAChR-
induced glucose uptake by the AMPK inhibitor Compound C (Comp C). Cells were treated with either vehicle or 20 μMCompound C for 30 min and then exposed to either vehicle
or 100 μM CCh. (F) Expression of AMPKα1 DN mutant inhibits CCh-induced glucose uptake. Cells infected with either null control adenovirus (null-ADV) or ADV encoding the
AMPKα1 DNmutant (AMPKα1 DN)were treated with either vehicle or CCh (100 μM). Values are reported as percent of control (null-ADV+ vehicle) and are the mean± SEM of
three experiments. ***P b 0.001, *P b 0.05 vs control; ##P b 0.01, #P b 0.05 by ANOVA followed by Newman–Keuls post hoc test.
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that in human platelets the communication between STIM1 and
TRPC1 occurs through Orai1 [45], whereas in transfected cell systems
it has been demonstrated that STIM1 binds directly to TRPC1 through
its cytosolic carboxyl terminus [56]. We found little or no STIM1 immu-
noreactivity co-immunoprecipitated with TRPC1 in either control or
CCh-stimulated SH-SY5Y cells, suggesting that following CCh-induced
Ca2+ store depletion either STIM1 does not interact with TRPC1 or,
more likely, the amount of STIM1 that can be associated with
immunoprecipitated TRPC1 is too low to be detected by the immuno-
blot procedure employed. Additional studies are necessary to determine
whether in SH-SY5Y cells mAChR stimulation can regulate the forma-
tion of STIM1–Orai–TRPC1 ternary complex and whether TRPC1 plays
a role in mAChR regulation of AMPK activity.
Recent studies have revealed that STIM proteins can control not only
store-operated channel activity but also a number of other plasma
membrane constituents regulating cellular Ca2+ homeostasis [37]. Forinstance, it has been reported that in airway smooth muscle cells
STIM1 knockdown blocks histamine-induced stimulation of NCX1-
mediated reverse mode Na+/Ca2+ exchange [57], an additional route
of agonist-induced Ca2+ entry. In the present study we found that the
reverse mode Na+/Ca2+ exchange inhibitor KB-R7943, at a concentra-
tion reported to block agonist-induced Ca2+ signals in smooth muscle
cells [57], was without effect on muscarinic stimulation of AMPK phos-
phorylation, lessening the possibility that Ca2+ inﬂux via reverse mode
Na+/Ca2+ exchange sustained this response.
Unlike AMPK regulation, ERK1/2 phosphorylation induced by CCh
was not affected by STIM1 depletion. While this ﬁnding supports the
speciﬁcity of STIM1 siRNA treatment, it also highlights the occurrence
of STIM1-dependent and STIM1-independent signaling pathways trig-
gered by mAChRs in SH-SY5Y cells. This observation is consistent with
a previous study demonstrating that in transfected CHO cells ERK1/2
phosphorylation induced by either M2 or M3 mAChRs was independent
of extracellular Ca2+ and resistant to Ca2+ store depletion [58].
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of themainmetabolic effects exerted by AMPK in different cell types [8]
and AMPK has been shown to be involved in the stimulation of glucose
uptake by G protein-coupled receptors in cells of peripheral tissues [12,
13]. However, little is known on the participation of AMPK in the control
of glucose uptake in cells of neural origin. The present study shows for
the ﬁrst time that in SH-SY5Y cells activation of mAChRs induces a sig-
niﬁcant increase in glucose uptake and provides evidence that this re-
sponse is mediated by the M3 subtype and dependent on activation of
the SOCE–CaMKKβ–AMPK signaling pathway. Thus, the potency of
CCh in eliciting this response was similar to that displayed in enhancing
AMPK and ACC phosphorylation. As observed for AMPK stimulation,
mAChR-induced glucose uptake was blocked by 4-DAMP, insensitive
to MT-7, suppressed in the absence of extracellular Ca2+ and signiﬁ-
cantly reduced by 2-APB treatment and STIM1 knockdown. Moreover,
the stimulation of glucose uptakewasmarkedly inhibited by pharmaco-
logical inhibition of either CaMKKβ with STO609 or AMPK with Com-
pound C and by ADV expression of an AMPKα1 DN mutant.
It is known that AMPK promotes glucose uptake by enhancing the
membrane expression of GLUT4 in muscle and the membrane translo-
cation and/or activity of GLUT1 in different cell types [8]. SH-SY5Y
cells have been reported to express GLUT1, GLUT3 and GLUT4 [59,60].
In the present study stimulation of glucose uptake by CCh was
completely suppressed by cytochalasin B and phloretin, which are
known to inhibit glucose transporters of the GLUT family. Additional
studies are required to identify the nature of the GLUT protein(s) and
the underlying regulatorymechanisms involved inmAChRs stimulation
of glucose uptake through SOCE-activated AMPK.
AMPK and Gq/11-coupled M3 mAChRs have been shown to play a
critical role in regulating cellular energy homeostasis and are currently
considered important pharmacological targets for the treatment of
type 2 diabetes [2,8]. Moreover, there is evidence that both mAChRs
and AMPK promote neuronal survival against different type of stressors
[9,10,61]. By using SH-SY5Y cells as a relatively simple model of neural
cells expressing functional mAChRs, the present study shows that
SOCE is critical for the coupling of M3 mAChR signaling to activation of
AMPK and stimulation of glucose uptake. Although SOCE is considered
the main route of Ca2+ entry in non-excitable cells, there is evidence
that SOCE occurs in neurons [62], where it has been proposed to regu-
late spontaneous transmitter release [63] and Ca2+ homeostasis follow-
ing injury [64], and it may be protective against neurodegenerative
diseases, such as Alzheimer disease [65,66]. Thus, the demonstration
of a functional coupling betweenM3mAChRs, SOCE andAMPK signaling
may disclose new mechanisms mediating the cholinergic control of
neuronal energy metabolism and survival.
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